CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer.
10.12122/j.issn.1673-4254.2022.09.01
- Author:
Li GUO
1
;
Yin Ling MA
1
;
Ting LI
1
;
Jin Ping LI
2
Author Information
1. Ningxia Medical University, Yinchuan 750000, China.
2. General Hospital of Ningxia Medical University, Yinchuan 750000, China.
- Publication Type:Journal Article
- Keywords:
CD40LG;
TCGA;
breast cancer;
tumor microenvironment;
tumor-infiltrating immune cells
- MeSH:
Biomarkers, Tumor/metabolism*;
Breast Neoplasms/genetics*;
Female;
Gene Expression Profiling;
Gene Expression Regulation, Neoplastic;
Humans;
Prognosis;
RNA;
RNA, Messenger;
Tumor Microenvironment/genetics*
- From:
Journal of Southern Medical University
2022;42(9):1267-1278
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To identify tumor microenvironment (TME)- related genes associated with the occurrence of invasive breast cancer as potential prognostic biomarkers and therapeutic targets.
METHODS:RNA transcriptome data and clinically relevant data were retrieved from TCGA database, and the StromalScore and ImmuneScore were calculated using the ESTIMATE algorithm. The differentially expressed genes (DEGs) were screened by taking the intersection. A protein- protein interaction network was established, and univariate COX regression analysis was used to identify the core genes among the DEGs. A core gene was selected for GSEA and CIBERSORT analysis to determine the function of the core gene and the proportion of tumor-infiltrating immune cells, respectively. Western blotting and qRT-PCR were performed to verify the expression level of CD40LG in breast cancer cell lines and clinical specimens.
RESULTS:A total of 1222 samples (124 normal and 1098 tumor samples) were extracted from TCGA for analysis, from which 487 DEGs were identified. These genes were mainly enriched in immune-related pathways, and crossover analysis identified 11 key genes (CD40LG, ITK, CD5, CD3E, SPN, IL7R, CD48, CCL19, CD2, CD52, and CD2711) associated with breast cancer TME status. CD40LG was selected as the core gene, whose high expression was found to be associated with a longer overall survival of breast cancer patients (P=0.002), and its expression level differed significantly with TNM stage and tumor size (P < 0.05). GSEA and CIBERSORT analyses indicated that CD40LG expression level was associated with immune activity in the TME. Western blotting and qRT-PCR showed that the protein and mRNA expression of CD40LG were significantly lower in breast cancer cells and cancer tissues than in normal breast cells and adjacent tissues.
CONCLUSIONS:The high expression of CD40LG in TME is positively correlated with the survival of patients with invasive breast cancer, suggesting its value as a potential new biomarker for predicting prognosis of the patients.
